Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

NCT05898464 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT05898464
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05898464 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV
Lead sponsor
Seoul National University Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 27, 2023
Completion date
February 10, 2026
Enrollment
71 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

vaccination; infection, vaccine adverse reaction